• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大安大略省专门多学科心力衰竭诊所的成本效益。

Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada.

机构信息

Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

出版信息

Value Health. 2010 Dec;13(8):915-21. doi: 10.1111/j.1524-4733.2010.00797.x. Epub 2010 Nov 23.

DOI:10.1111/j.1524-4733.2010.00797.x
PMID:21091970
Abstract

BACKGROUND

Specialized multidisciplinary clinics have been shown to reduce mortality in heart failure (HF). Our objective was to evaluate the cost-effectiveness of this model of care delivery.

METHODS

We performed a cost-effectiveness analysis, with a 12-year time horizon, from the perspective of the Ontario Ministry of Health and Long-term Care, comparing a standard care cohort, consisting of all patients admitted to hospital with HF in 2005, to a hypothetical cohort treated in HF clinics. Survival curves describing the natural history of HF were constructed using mortality estimates from the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study. Survival benefits and resource uptake associated with HF clinics were estimated from a meta-analysis of published trials. HF clinics costs were obtained by costing a representative clinic in Ontario. Health-related costs were determined through linkage to administrative databases. Outcome measures included life expectancy (years), costs (in 2008 Canadian dollars) and the incremental cost-effectiveness ratio (ICER).

RESULTS

HF clinics were associated with a 29% reduction in all-cause mortality (risk ratio [RR] 0.71; 95% confidence interval [CI] 0.56-0.91) but a 12% increase in hospitalizations (RR 1.12; 95% CI 0.92-1.135). The cost of care in HF clinics was $52 per 30 patient-days. Projected life-expectancy of HF clinic patients was 3.91 years, compared to 3.21 years for standard care. The 12-year cumulative cost per patient in the HF clinic group was $66,532 versus $53,638 in the standard care group. The ICER was $18,259/life-year gained.

CONCLUSIONS

HF clinics appear to be a cost effective way of delivering ambulatory care to HF patients.

摘要

背景

专门的多学科诊所已被证明可以降低心力衰竭(HF)的死亡率。我们的目的是评估这种护理模式的成本效益。

方法

我们进行了一项成本效益分析,时间范围为 12 年,从安大略省卫生部和长期护理的角度出发,将 2005 年因 HF 住院的所有患者组成的标准护理队列与假设的 HF 诊所治疗队列进行比较。使用来自增强有效心脏治疗反馈(EFFECT)研究的死亡率估计值构建描述 HF 自然史的生存曲线。HF 诊所的生存获益和资源利用情况来自对已发表试验的荟萃分析进行估算。通过对安大略省一家代表性诊所进行成本核算获得 HF 诊所的成本。通过与行政数据库进行链接确定与健康相关的成本。结果指标包括预期寿命(年)、成本(2008 年加元)和增量成本效益比(ICER)。

结果

HF 诊所与全因死亡率降低 29%相关(风险比[RR]0.71;95%置信区间[CI]0.56-0.91),但住院率增加 12%(RR 1.12;95%CI 0.92-1.135)。HF 诊所的护理成本为每位患者每 30 天 52 美元。HF 诊所患者的预期寿命为 3.91 年,而标准护理为 3.21 年。HF 诊所组患者 12 年的累计每位患者成本为 66532 美元,而标准护理组为 53638 美元。ICER 为每增加 1 个生命年花费 18259 美元。

结论

HF 诊所似乎是为 HF 患者提供门诊护理的一种具有成本效益的方法。

相似文献

1
Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada.加拿大安大略省专门多学科心力衰竭诊所的成本效益。
Value Health. 2010 Dec;13(8):915-21. doi: 10.1111/j.1524-4733.2010.00797.x. Epub 2010 Nov 23.
2
The effect of multidisciplinary heart failure clinic characteristics on 1-year postdischarge health care costs: a population-based study.多学科心力衰竭诊所特征对出院后 1 年医疗保健费用的影响:一项基于人群的研究。
Med Care. 2014 Mar;52(3):272-9. doi: 10.1097/MLR.0000000000000071.
3
Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.慢性心力衰竭的成本/效用比:日间医院提供的心力衰竭管理项目与常规护理的比较。
J Am Coll Cardiol. 2002 Oct 2;40(7):1259-66. doi: 10.1016/s0735-1097(02)02140-x.
4
Insights into the contemporary management of heart failure in specialized multidisciplinary ambulatory clinics.专业多学科门诊诊所中心力衰竭当代管理的新视角。
Can J Cardiol. 2013 Sep;29(9):1062-8. doi: 10.1016/j.cjca.2013.01.017. Epub 2013 Apr 24.
5
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure.依普利酮与安慰剂相比在心肌梗死合并左心室功能不全和心力衰竭患者中的成本效益。
Circulation. 2005 Mar 8;111(9):1106-13. doi: 10.1161/01.CIR.0000157146.86758.BC. Epub 2005 Feb 21.
6
Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).N-末端脑利钠肽前体指导治疗老年心力衰竭患者的成本效益:TIME-CHF 研究(充血性心力衰竭老年患者强化与标准药物治疗比较试验)的结果。
JACC Heart Fail. 2013 Feb;1(1):64-71. doi: 10.1016/j.jchf.2012.08.002. Epub 2013 Feb 4.
7
Cost-effectiveness of supervised exercise therapy in heart failure patients.心力衰竭患者监督下运动疗法的成本效益。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S100-7. doi: 10.1016/j.jval.2011.05.006.
8
Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).慢性心力衰竭家庭管理与门诊管理的成本效益:一项实用多中心随机试验队列的延长随访——“WHICH?”研究(哪种心力衰竭干预措施在减少住院治疗方面最具成本效益且对消费者最友好)
Int J Cardiol. 2015 Dec 15;201:368-75. doi: 10.1016/j.ijcard.2015.08.066. Epub 2015 Aug 8.
9
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.植入式心脏复律除颤器辅助或不辅助的心脏再同步治疗的长期成本效益
Eur Heart J. 2007 Jan;28(1):42-51. doi: 10.1093/eurheartj/ehl382. Epub 2006 Nov 16.
10
Cost-utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.NT-proBNP 指导的多学科治疗慢性心力衰竭的成本-效用分析。
Int J Technol Assess Health Care. 2013 Jan;29(1):3-11. doi: 10.1017/S0266462312000712. Epub 2012 Dec 20.

引用本文的文献

1
Heart failure: assessment of the global economic burden.心力衰竭:全球经济负担评估
Eur Heart J. 2025 Aug 14;46(31):3069-3078. doi: 10.1093/eurheartj/ehaf323.
2
Heart failure clinic inclusion and exclusion criteria: cross-sectional study of clinic's and referring provider's perspectives.心力衰竭诊所纳入和排除标准:对诊所和转诊医生观点的横断面研究。
BMJ Open. 2024 Mar 14;14(3):e076664. doi: 10.1136/bmjopen-2023-076664.
3
Heart failure in Nigeria: protocol for a systematic review and meta-analysis.尼日利亚心力衰竭:系统评价和荟萃分析方案。
Afr Health Sci. 2023 Jun;23(2):530-536. doi: 10.4314/ahs.v23i2.61.
4
Factors Affecting Referral and Patient Access to Heart Function Clinics in Ontario: A Qualitative Study of Stakeholders.影响安大略省心脏功能诊所转诊及患者就诊的因素:一项利益相关者的定性研究
CJC Open. 2023 Mar 9;5(6):421-428. doi: 10.1016/j.cjco.2023.03.002. eCollection 2023 Jun.
5
Multidisciplinary amyloidosis care in the era of personalized medicine.个性化医疗时代的多学科淀粉样变性病护理
Front Neurol. 2022 Oct 13;13:935936. doi: 10.3389/fneur.2022.935936. eCollection 2022.
6
Assessment of Primary Health Care Specialized Reference Clinics in Riyadh First Health Cluster: Outcome, Cost-Effectiveness and Patient Satisfaction.利雅得首个健康集群初级卫生保健专科参考诊所评估:结果、成本效益与患者满意度
Clinicoecon Outcomes Res. 2022 May 5;14:371-381. doi: 10.2147/CEOR.S355507. eCollection 2022.
7
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review.门诊心力衰竭护士主导服务的临床有效性和成本效益:一项综合综述。
BMC Cardiovasc Disord. 2022 Feb 22;22(1):64. doi: 10.1186/s12872-022-02509-9.
8
Multidisciplinary clinics for colorectal cancer may not provide more efficient coordination of care.结直肠癌多学科会诊可能无法提供更有效的护理协调。
Am J Surg. 2022 Jun;223(6):1167-1171. doi: 10.1016/j.amjsurg.2021.11.027. Epub 2021 Dec 4.
9
What Every Internist-Endocrinologist Should Know about Rare Genetic Syndromes in Order to Prevent Needless Diagnostics, Missed Diagnoses and Medical Complications: Five Years of 'Internal Medicine for Rare Genetic Syndromes'.为避免不必要的诊断、漏诊及医疗并发症,每位内科内分泌科医生应了解的罕见遗传综合征知识:“罕见遗传综合征的内科治疗”五年回顾
J Clin Med. 2021 Nov 22;10(22):5457. doi: 10.3390/jcm10225457.
10
Automatic referrals within a cystic fibrosis multidisciplinary clinic improve patient evaluation and management.囊性纤维化多学科诊所内的自动转诊可改善患者评估和管理。
J Clin Transl Endocrinol. 2021 Jun 12;24:100259. doi: 10.1016/j.jcte.2021.100259. eCollection 2021 Mar.